Peptide Purity
The proportion of a peptide preparation that consists of the target compound rather than related impurities, synthesis byproducts, or degradation products.
Definition
Peptide purity describes the compositional quality of a synthesized peptide preparation, specifically the fraction of the total peptide content represented by the intended, fully correct sequence. Research-grade peptides are characterized by HPLC purity, expressed as the percentage of total UV-absorbing area attributable to the main compound peak. Common impurities in synthesized peptides include truncated sequences (peptides where synthesis stopped before completion), deletion sequences (peptides missing one or more internal residues), oxidation products (particularly at methionine and tryptophan residues), and racemization products. Purity directly affects the reliability and interpretability of biological research results.
Research Context
Peptide purity is a critical variable in research compound quality because impurities can independently affect biological assay results, complicate pharmacokinetic interpretation, and make research irreproducible when lot-to-lot purity varies. Research-grade peptides at 98% or greater purity by HPLC are the standard for serious preclinical research because this level of purity minimizes the potential for confounding biological effects from synthesis impurities. Researchers should treat purity as a minimum specification and avoid compounds with purity below 95% for any mechanistic research application.
Relevant Compounds
This term applies to the following research compound hubs.
Frequently Asked Questions
Explore the Research Library
Compound comparisons, research use cases, study indexes, and more. A complete reference for research-grade peptide science.